| Tomblyn M, Lazarus HM
Donor lymphocyte infusions: the long and winding road: how should it be traveled? [JOURNAL ARTICLE]
Bone Marrow Transplant 2008 Aug 18.
Abstract | Full Citation |
| Zhang M, Fu W, Prabhu S, et al.
Inhibition of Polysome Assembly Enhances Imatinib Activity Against Chronic Myelogenous Leukemia, and Overcomes Imatinib Resistance. [JOURNAL ARTICLE]
Mol Cell Biol 2008 Aug 11.
Abstract | Full Citation |
| Shah NP
Advanced CML: therapeutic options for patients in accelerated and blast phases. [Journal Article]
J Natl Compr Canc Netw 2008 Mar.:S31-S36.
Abstract | Full Citation | Find Related Articles |
| Thavaraj V, Seth R
Prophylaxis of central nervous system leukemia: a case of chronic myeloid leukemia with lymphoid blast crisis treated with imatinib mesylate. [Journal Article]
World J Pediatr 2008 May; 4(2):145-7.
Abstract | Full Citation | Find Related Articles |
| Wachowiak J, Labopin M, Miano M, et al.
Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach Programme. [Journal Article]
Bone Marrow Transplant 2008 Jun.:S112-7.
Abstract | Full Citation | Find Related Articles |
| Hui RC, Gomes AR, Constantinidou D, et al.
The forkhead transcription factor FOXO3a increases PI3K/Akt activity in drug-resistant leukaemic cells through induction of PIK3CA expression. [JOURNAL ARTICLE]
Mol Cell Biol 2008 Jul 21.
Abstract | Full Citation | Find Related Articles |
| Joshi S, Sunita P, Deshmukh C, et al.
Bone marrow morphological changes in patients of chronic myeloid leukemia treated with imatinib mesylate. [JOURNAL ARTICLE]
Indian J Cancer 2008 April-June; 45(2):45-49.
Abstract | Full Citation | Find Related Articles |
| Kamitsuji Y, Kuroda J, Kimura S, et al.
The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias. [JOURNAL ARTICLE]
Cell Death Differ 2008 Jul 11.
Abstract | Full Citation |
| Huang KP, Chase AJ, Cross NC, et al.
Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia. [JOURNAL ARTICLE]
Int J Hematol 2008 Jul 2.
Abstract | Full Citation |
| Rodrigues MS, Reddy MM, Sattler M
Cell Cycle Regulation by Oncogenic Tyrosine Kinases in Myeloid Neoplasias: From Molecular Redox Mechanisms to Health Implications. [JOURNAL ARTICLE]
Antioxid Redox Signal 2008 Jul 1.
Abstract | Full Citation |
  |
